SEC Filings for Anika Therapeutics Inc. (ANIK)

$ 42.75   0.75 (+1.79%) Volume: 374.94k 4:00 PM EST Feb 21, 2020
Filing Type:
Form TypeForm DescriptionPagesDateView
8-KCurrent report pursuant to Section 13 or 15(d)207/26/2017
8-KCurrent report pursuant to Section 13 or 15(d)1807/14/2017
S-8Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans907/07/2017
4Statement of changes in beneficial ownership of securities107/06/2017
8-KCurrent report pursuant to Section 13 or 15(d)4506/19/2017
4Statement of changes in beneficial ownership of securities105/23/2017
8-K/A[Amend]Current report pursuant to Section 13 or 15(d)605/05/2017
10-QGeneral form for quarterly reports under Section 13 or 15(d)2305/04/2017
8-KCurrent report pursuant to Section 13 or 15(d)505/03/2017
8-KCurrent report pursuant to Section 13 or 15(d)604/28/2017
DEFA14AAdditional proxy soliciting materials - definitive504/28/2017
DEF 14AOther definitive proxy statements6704/28/2017
4Statement of changes in beneficial ownership of securities102/28/2017
4Statement of changes in beneficial ownership of securities102/28/2017
4Statement of changes in beneficial ownership of securities102/28/2017
2345678910111213141516